Grifols reported EUR21.41B in Assets for its fiscal quarter ending in December of 2024.


Assets Change Date
Alaunos Therapeutics USD 2.76M 795K Dec/2024
GlaxoSmithKline GBP 59.26B 1.45B Jun/2025
Grifols EUR 21.41B 1.12B Dec/2024
Life Technologies USD 101.53M 4.7M Jun/2025